| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Fowler John Franklin is a CEO at Kezar Life Sciences, Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2020 | KZR Kezar Life Sciences, Inc. | CEO | Buy | 38,461 | $2.60 | $99,998.60 | New | |
| Oct 10, 2019 | KZR Kezar Life Sciences, Inc. | CEO | Buy | 1,000 | $3.24 | $3,235.40 | +0.3% | |
| Aug 13, 2019 | KZR Kezar Life Sciences, Inc. | CEO | Buy | 2,000 | $4.66 | $9,310.00 | +0.7% | |
| Aug 9, 2019 | KZR Kezar Life Sciences, Inc. | CEO | Buy | 1,250 | $5.11 | $6,388.53 | +0.2% |